SCHEMBL5383053

SCHEMBL5383053

O=C(O)NCc1ccc(NC(=S)NC(=O)c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 5/20 0.68
ALDH1A1 P00352 6/20 0.67
MITF O75030 1/20 0.67
POLB P06746 2/20 0.65
LMNA P02545 2/20 0.64
HPGD P15428 1/20 0.64
MAPK1 P28482 1/20 0.64
NPC1 O15118 1/20 0.63
RAB9A P51151 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
MEN1 O00255 2/20 0.63
KMT2A Q03164 2/20 0.63
ALOX12 P18054 1/20 0.63
RECQL P46063 1/20 0.63
KDM4E B2RXH2 2/20 0.59
CA1 P00915 1/20 0.58
CA2 P00918 1/20 0.58
PLK1 P53350 1/20 0.58
CA9 Q16790 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8611590 0.85 ALDH1A1 (0.84) EPHX1ALDH1A1POLBLMNAHPGD
SCHEMBL3896605 0.85 MAOB (0.67) ALDH1A1POLBHPGDNPC1RAB9A
SCHEMBL5386906 0.83 ALDH1A1 (0.56) EPHX1ALDH1A1MITFPOLBLMNA
N-(Phenylcarbamothioyl)Benzamide SCHEMBL2341910 0.82 EPHX1 (1.00) EPHX1ALDH1A1POLBHPGDNPC1
SCHEMBL24799815 0.81 EPHX1 (0.78) EPHX1ALDH1A1POLBNPC1RAB9A
SCHEMBL5457898 0.81 ALDH1A1 (0.81) EPHX1ALDH1A1LMNANPC1RAB9A
SCHEMBL14096444 0.81 ALDH1A1 (1.00) ALDH1A1MITFPOLBLMNAHPGD
SCHEMBL8616503 0.81 EPHX1 (0.83) EPHX1ALDH1A1POLBLMNAHPGD
SCHEMBL12069951 0.80 MEN1 (0.89) ALDH1A1MITFPOLBLMNANPC1
SCHEMBL6681065 0.80 HDAC6 (0.59) EPHX1ALDH1A1MITFLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273880-B2 Selective NPY (Y5) antagonists H. LUNBECK A/S (DK) 2007-09-25 US disclosed
EP-1194421-B1 SELECTIVE NPY (Y5) ANTAGONISTS LUNDBECK & CO AS H (DK) 2005-10-12 EP disclosed
US-20050137240-A1 Selective NPY (Y5) antagonists H. LUNDBECK A/S (DK) 2005-06-23 US disclosed
US-6225330-B1 Selective NPY (Y5) antagonists (tricyclics) SYNAPTIC PHARMACEUTICAL CORPORATION 2001-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137240-A1 Selective NPY (Y5) antagonists NPY5R, NPY1R, NPY2R EPHX1 3465/4885ALDH1A1 4658/4885MITF 951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.